Urine is an ideal clinical specimen because it is excreted in large quantities, collection is non-invasive, and it can be self-sampled.

Urine specimens can be used in the early detection of minimal residual disease (MRD) of bladder cancer, kidney cancer, cervical cancer and prostate cancer. However, urine contains substances such as urea and nucleases that can damage DNA or inhibit the PCR reaction. Meridian’s Liquid Biopsy Urine qPCR Mix is unique in that it enables highly sensitive, very fast detection of target DNA directly from high concentrations of urine. Furthermore, this mix can be used in a wet format or lyophilized to create ambient-temperature stable.